Author

Harald Vogelsang 1

1 AKH Medical University, Vienna, Austria

DIAGNOSTIC DELAY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - A STUDY OF THE AUSTRIAN IBD STUDY GROUP (ATISG)

Gottfried Novacek, Hans Peter Gröchenig, Thomas Haas, Heimo Helmut Wenzl, Pius Steiner, Robert Koch, Thomas Feichtenschlager, Gerald Eckhardt, Andreas Mayer, Andreas Kirchgatterer, Othmar Ludwiczek, Reingard Platzer, Pavol Papay, Johanna Gartner, Harry Fuchssteiner, Wolfgang Miehsler, Paul-Gerhard Peters, Gerhard Reicht,

High versus standard adalimumab induction dosing regimens in patients with moderately to severely active ulcerative colitis: results from the SERENE-UC induction study

Julian Panés, Jean-Frederic Colombel, Geert R. D'Haens, Stefan Schreiber, Remo Panaccione, Laurent Peyrin-Biroulet, Edward Loftus, Jr, Silvio Danese, Edouard Louis, Alessandro Armuzzi, Marc Ferrante, Harald Vogelsang, Jessica Lefebvre, Thao Doan, Nisha V. Kwatra, Nael M. Mostafa, Wangang Xie, Bidan Huang, Joel Petersson;;

MARKERS OF INTESTINAL INFLAMMATION ARE COMMONLY ELEVATED IN LUNG-TRANSPLANTED PATIENTS WITH CYSTIC FIBROSIS

Emina Halilbasic, Katharina Staufer, Solveig Harm, Peter Jaksch, Walter Klepetko, Harald Vogelsang, Michael Trauner, Lili Kazemi-Shirazi

IBDOC ? FIRST SMARTPHONE BASED CALPROTECTIN HOME TEST ? 18 MONTHS EXPERIENCE

Christian Reinhard, Alicja Ritz, Marie-Eve Überschlag, Anita Beyer, Harald Vogelsang, Jakob Weber

INFORMATION NECESSARY TO PREDICT INDIVIDUAL INFLIXIMAB (IFX) PHARMACOKINETICS (PK) IN PATIENTS WITH IBD

Alexander Eser, Harald Vogelsang, Gottfried Novacek, Sieglinde Reinisch, Christian Primas, Sonja Brehovsky, Diane R. Mould, Walter Reinisch

WITHDRAWAL OF AZATHIOPRINE IN PATIENTS WITH CROHN’S DISEASE IN STABLE CLINICAL REMISSION: A DOUBLE-BLIND, PLACEBO-CONTROLLED 2 YEARS TRIAL

Heimo Helmut Wenzl, Christian Primas, Gottfried Novacek, Alexander Teml, Anna Öfferlbauer-Ernst, Christoph Högenauer, Harald Vogelsang, Wolfgang Petritsch, Walter Reinisch

ASSOCIATION BETWEEN ELEVEN THIOPURINE METABOLITES AND MUCOSAL HEALING IN PATIENTS WITH CROHN’S DISEASE

Sieglinde Reinisch, Ute Hofmann, Cornelia Lichtenberger, Stefan Winter, Alexander Eser, Alexander Teml, Clemens Dejaco, Gottfried Novacek, Harald Vogelsang, Elke Schäffeler, Matthias Schwab, Walter Reinisch

ADALIMUMAB (ADA) AND INFLIXIMAB (IFX) THERAPY DURING PREGNANCY IN IBD: A PROSPECTIVE ASSESSMENT OF OUTCOME, SAFETY, ANTI-TNFΑ CORD BLOOD AND FOLLOW UP BLOOD LEVELS IN NEWBORNS

Stefan Traussnigg, Alexander Eser, Christian Primas, Pavol Papay, Cornelia Gratzer, Andrea Mikulits, Sieglinde Reinisch, Walter Reinisch, Michael Trauner, Harald Vogelsang, Gottfried Novacek, Clemens Dejaco

ANTI-DRUG ANTIBODIES INHIBIT NEUTRALIZATION OF TNF-ALPHA IN INFLIXIMAB TREATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)

Alexander Eser, Harald Vogelsang, Sieglinde Reinisch, Gottfried Novacek, Clemens Dejaco, Lili Kazemi-Shirazi, Christian Primas, Sonja Brehovsky, Xinjun Liu, Sharat Singh, Walter Reinisch

INFLIXIMAB AND ADALIMUMAB IN TNF-ΑNAÏVE CROHN`S DISEASE PATIENTS: AUSTRIAN MULTICENTRE COHORT STUDY

Pavol Papay, Stephanie Kainz, Wolfgang Petritsch, Thomas Haas, Thomas Feichtenschlager, Gottfried Novacek, Alexander Eser, Harald Vogelsang, Walter Reinisch

Item 1 - 10 / 11
1
2